Prognostic Value of the Neutrophil-Lymphocyte Ratio in Triple Negative Breast Cancer Patients.

Shi, Kate; Westhuyzen, Justin; Gortman, Aron; Shakespeare, Thomas P; Aherne, Noel J

Shi, Kate; Westhuyzen, Justin; Gortman, Aron; Shakespeare, Thomas P; Aherne, Noel J.

Afiliação

Shi K; Department of Radiation Oncology, Mid-North Coast Cancer Institute, Coffs Harbour, Australia.
Westhuyzen J; Department of Radiation Oncology, Mid-North Coast Cancer Institute, Coffs Harbour, Australia.
Gortman A; Department of Radiation Oncology, North Coast Cancer Institute, Lismore, New South Wales, Australia.
Shakespeare TP; Department of Radiation Oncology, Mid-North Coast Cancer Institute, Coffs Harbour, Australia.
Aherne NJ; University of New South Wales, Sydney, Australia.

Ann Clin Lab Sci ; 52(1): 33-39, 2022 Jan.

Article em En | MEDLINE | ID: mdl-35181616

Assuntos

Neoplasias de Mama Triplo Negativas; Intervalo Livre de Doença; Humanos; Contagem de Linfócitos; Linfócitos/patologia; Neutrófilos/patologia; Prognóstico; Estudos Retrospectivos; Neoplasias de Mama Triplo Negativas/patologia

Palavras-chave

Dose fractionation; Mastectomy; Radiotherapy; Survival analysis; Triple negative breast neoplasms

Buscar no Google

Imprimir

XML

PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Buscar no Google

Imprimir

XML

PubMed Links